Literature DB >> 7359917

An investigation of the cause of death from cancer.

L Houten, A A Reilley.   

Abstract

Four thousand seven hundred twenty-eight autopsies performed at the Roswell Park Memorial Institute were reviewed to determine causes of death from cancer. The duration of the disease from the date of diagnosis to death, the primary site of the tumor, a detailed description of the presence or absence of metastatic tumor at a series of sites, and an estimate of the total tumor mass were included in the evaluation. Twenty-three common primary sites were selected for investigation. These sites represented 99% of the total series. Nine causes of death were described. These were respiratory failure, infection, toxic drug reaction, hepatic failure, renal failure, shock or heart failure, adrenal gland failure, electrolyte imbalance, and central nervous system failure. Some of these associations were obviuosly due to the direct destruction of the organ in question. There are some differences, however, comparing lung lesions to hepatic lesions. These and other factors are recited in the text.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7359917     DOI: 10.1002/jso.2930130205

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  14 in total

1.  Nutritional status, acute phase response and depression in metastatic lung cancer patients: correlations and association prognosis.

Authors:  Zoe Giannousi; Ioannis Gioulbasanis; Athanasios G Pallis; Alexandros Xyrafas; Danai Dalliani; Kostas Kalbakis; Vassilis Papadopoulos; Dimitris Mavroudis; Vassilis Georgoulias; Christos N Papandreou
Journal:  Support Care Cancer       Date:  2011-10-01       Impact factor: 3.603

2.  The p97/VCP ATPase is critical in muscle atrophy and the accelerated degradation of muscle proteins.

Authors:  Rosanna Piccirillo; Alfred L Goldberg
Journal:  EMBO J       Date:  2012-07-06       Impact factor: 11.598

3.  Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer.

Authors:  Clifford J Whatcott; Caroline H Diep; Ping Jiang; Aprill Watanabe; Janine LoBello; Chao Sima; Galen Hostetter; H Michael Shepard; Daniel D Von Hoff; Haiyong Han
Journal:  Clin Cancer Res       Date:  2015-02-18       Impact factor: 12.531

Review 4.  Orchestrating the Tumor Microenvironment to Improve Survival for Patients With Pancreatic Cancer: Normalization, Not Destruction.

Authors:  Clifford J Whatcott; Haiyong Han; Daniel D Von Hoff
Journal:  Cancer J       Date:  2015 Jul-Aug       Impact factor: 3.360

5.  Effect of colon cancer and surgical resection on skeletal muscle mitochondrial enzyme activity in colon cancer patients: a pilot study.

Authors:  Bethan E Phillips; Kenneth Smith; Sarah Liptrot; Philip J Atherton; Krishna Varadhan; Michael J Rennie; Mike Larvin; Jonathan N Lund; John P Williams
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-05-31       Impact factor: 12.910

Review 6.  ER Stress and Unfolded Protein Response in Cancer Cachexia.

Authors:  Anirban Roy; Ashok Kumar
Journal:  Cancers (Basel)       Date:  2019-12-03       Impact factor: 6.639

7.  Theophylline is able to partially revert cachexia in tumour-bearing rats.

Authors:  Mireia Olivan; Jochen Springer; Sílvia Busquets; Anika Tschirner; Maite Figueras; Miriam Toledo; Cibely Fontes-Oliveira; Maria Inés Genovese; Paula Ventura da Silva; Angelica Sette; Francisco J López-Soriano; Stefan Anker; Josep M Argilés
Journal:  Nutr Metab (Lond)       Date:  2012-08-21       Impact factor: 4.169

8.  Formoterol in the treatment of experimental cancer cachexia: effects on heart function.

Authors:  Míriam Toledo; Jochen Springer; Sílvia Busquets; Anika Tschirner; Francisco J López-Soriano; Stefan D Anker; Josep M Argilés
Journal:  J Cachexia Sarcopenia Muscle       Date:  2014-08-29       Impact factor: 12.910

9.  Cancer cachexia-when proteasomal inhibition is not enough.

Authors:  Jens Fielitz
Journal:  J Cachexia Sarcopenia Muscle       Date:  2016-06-13       Impact factor: 12.910

Review 10.  Understanding cachexia as a cancer metabolism syndrome.

Authors:  P E Porporato
Journal:  Oncogenesis       Date:  2016-02-22       Impact factor: 7.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.